{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T21:57:20Z","timestamp":1780955840300,"version":"3.54.1"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31871370"],"award-info":[{"award-number":["31871370"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82101779"],"award-info":[{"award-number":["82101779"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2021M700936"],"award-info":[{"award-number":["2021M700936"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2019A1515011342"],"award-info":[{"award-number":["2019A1515011342"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004000","name":"Guangzhou Science and Technology Program key projects","doi-asserted-by":"publisher","award":["202102010176"],"award-info":[{"award-number":["202102010176"]}],"id":[{"id":"10.13039\/501100004000","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2019YFA0801703"],"award-info":[{"award-number":["2019YFA0801703"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.cca.2022.01.021","type":"journal-article","created":{"date-parts":[[2022,1,29]],"date-time":"2022-01-29T17:27:19Z","timestamp":1643477239000},"page":"90-97","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["The clinical value of PlGF and the sFlt1\/PlGF ratio in the management of hypertensive pregnancy disorders: A retrospective real-world study in China"],"prefix":"10.1016","volume":"528","author":[{"given":"Hao","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongbo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuaiyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.cca.2022.01.021_b0005","doi-asserted-by":"crossref","first-page":"e323","DOI":"10.1016\/S2214-109X(14)70227-X","article-title":"Global causes of maternal death: a WHO systematic analysis","volume":"2","author":"Say","year":"2014","journal-title":"Lancet Glob Health"},{"issue":"3","key":"10.1016\/j.cca.2022.01.021_b0010","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/jmwh.12725","article-title":"Hypertensive Disorders of Pregnancy: Overview and Current Recommendations","volume":"63","author":"Folk","year":"2018","journal-title":"J. Midwifery Womens Health"},{"issue":"5","key":"10.1016\/j.cca.2022.01.021_b0015","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/s41581-019-0119-6","article-title":"Pre-eclampsia: pathogenesis, novel diagnostics and therapies","volume":"15","author":"Phipps","year":"2019","journal-title":"Nat. Rev. Nephrol."},{"issue":"1","key":"10.1016\/j.cca.2022.01.021_b0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejogrb.2013.05.005","article-title":"Global and regional estimates of preeclampsia and eclampsia: a systematic review","volume":"170","author":"Abalos","year":"2013","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"issue":"10","key":"10.1016\/j.cca.2022.01.021_b0025","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1097\/00004872-199715100-00001","article-title":"What's in a name? Problems with the classification of hypertension in pregnancy","volume":"15","author":"Brown","year":"1997","journal-title":"J. Hypertens"},{"issue":"2","key":"10.1016\/j.cca.2022.01.021_b0030","doi-asserted-by":"crossref","first-page":"189","DOI":"10.3109\/10641955.2013.784788","article-title":"Clinical characterization and outcomes of preeclampsia with normal angiogenic profile","volume":"32","author":"Rana","year":"2013","journal-title":"Hypertens Pregnancy"},{"issue":"5","key":"10.1016\/j.cca.2022.01.021_b0035","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1172\/JCI17189","article-title":"Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia","volume":"111","author":"Maynard","year":"2003","journal-title":"J. Clin. Invest."},{"issue":"7","key":"10.1016\/j.cca.2022.01.021_b0040","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1161\/CIRCULATIONAHA.111.054361","article-title":"Angiogenic factors and the risk of adverse outcomes in women with suspected preeclampsia","volume":"125","author":"Rana","year":"2012","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.cca.2022.01.021_b0045","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1161\/HYPERTENSIONAHA.119.13997","article-title":"Angiogenic Marker Prognostic Models in Pregnant Women With Hypertension","volume":"75","author":"Perry","year":"2020","journal-title":"Hypertension"},{"issue":"1","key":"10.1016\/j.cca.2022.01.021_b0050","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1056\/NEJMoa1414838","article-title":"Predictive Value of the sFlt-1:PlGF Ratio in Women with Suspected Preeclampsia","volume":"374","author":"Zeisler","year":"2016","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.cca.2022.01.021_b0055","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1161\/HYPERTENSIONAHA.119.12760","article-title":"Short-Term Prediction of Adverse Outcomes Using the sFlt-1 (Soluble fms-Like Tyrosine Kinase 1)\/PlGF (Placental Growth Factor) Ratio in Asian Women With Suspected Preeclampsia","volume":"74","author":"Bian","year":"2019","journal-title":"Hypertension"},{"issue":"5","key":"10.1016\/j.cca.2022.01.021_b0060","doi-asserted-by":"crossref","first-page":"518.e1","DOI":"10.1016\/j.ajog.2020.11.004","article-title":"Impact of new definitions of preeclampsia at term on identification of adverse maternal and perinatal outcomes","volume":"224","author":"Lai","year":"2021","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"5","key":"10.1016\/j.cca.2022.01.021_b0065","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1161\/HYPERTENSIONAHA.111.00754","article-title":"Circulating angiogenic factors and urinary prolactin as predictors of adverse outcomes in women with preeclampsia","volume":"61","author":"Lea\u00f1os-Miranda","year":"2013","journal-title":"Hypertension"},{"key":"10.1016\/j.cca.2022.01.021_b0070","doi-asserted-by":"crossref","unstructured":"ACOG Practice Bulletin No. 202: Gestational Hypertension and Preeclampsia, Obstet Gynecol 133(1) (2019) 1.","DOI":"10.1097\/AOG.0000000000003020"},{"key":"10.1016\/j.cca.2022.01.021_b0075","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.preghy.2018.06.017","article-title":"Clinical implementation of the sFlt-1\/PlGF ratio to identify preeclampsia and fetal growth restriction: A prospective cohort study","volume":"13","author":"Herraiz","year":"2018","journal-title":"Pregnancy Hypertens"},{"key":"10.1016\/j.cca.2022.01.021_b0080","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.ejogrb.2016.08.036","article-title":"Italian Advisory Board: sFlt-1\/PlGF ratio and preeclampsia, state of the art and developments in diagnostic, therapeutic and clinical management","volume":"206","author":"Di Martino","year":"2016","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"issue":"3","key":"10.1016\/j.cca.2022.01.021_b0085","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/uog.14799","article-title":"Implementation of the sFlt-1\/PlGF ratio for prediction and diagnosis of pre-eclampsia in singleton pregnancy: implications for clinical practice","volume":"45","author":"Stepan","year":"2015","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"10.1016\/j.cca.2022.01.021_b0090","doi-asserted-by":"crossref","unstructured":"Gestational Hypertension and Preeclampsia: ACOG Practice Bulletin, Number 222, Obstet Gynecol 135(6) (2020) e237-e260.","DOI":"10.1097\/AOG.0000000000003891"},{"key":"10.1016\/j.cca.2022.01.021_b0095","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.602560","article-title":"Short-Term Prediction of Preeclampsia in Chinese Women Using the Soluble fms-Like Tyrosine Kinase 1\/Placental Growth Factor Ratio: A Sub-Analysis of the PROGNOSIS Asia Study","volume":"8","author":"Gao","year":"2021","journal-title":"Front. Cardiovasc. Med."},{"issue":"2","key":"10.1016\/j.cca.2022.01.021_b0100","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1161\/HYPERTENSIONAHA.120.15146","article-title":"Prediction of Preeclampsia-Related Adverse Outcomes With the sFlt-1 (Soluble fms-Like Tyrosine Kinase 1)\/PlGF (Placental Growth Factor)-Ratio in the Clinical Routine: A Real-World Study","volume":"77","author":"Droge","year":"2021","journal-title":"Hypertension"},{"issue":"3","key":"10.1016\/j.cca.2022.01.021_b0105","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1161\/HYPERTENSIONAHA.120.15552","article-title":"Usefulness of the sFlt-1\/PlGF (Soluble fms-Like Tyrosine Kinase-1\/Placental Growth Factor) Ratio in Diagnosis or Misdiagnosis in Women With Clinical Diagnosis of Preeclampsia","volume":"76","author":"Lea\u00f1os-Miranda","year":"2020","journal-title":"Hypertension"},{"key":"10.1016\/j.cca.2022.01.021_b0110","doi-asserted-by":"crossref","unstructured":"D. Nzelu, D. Biris, T. Karampitsakos, K.K. Nicolaides, N.A. Kametas, First trimester serum angiogenic and anti-angiogenic factors in women with chronic hypertension for the prediction of preeclampsia, Am J Obstet Gynecol 222(4) (2020) 374 e1-374 e9.","DOI":"10.1016\/j.ajog.2019.10.101"},{"issue":"5","key":"10.1016\/j.cca.2022.01.021_b0115","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1161\/HYPERTENSIONAHA.108.127977","article-title":"First-trimester prediction of hypertensive disorders in pregnancy","volume":"53","author":"Poon","year":"2009","journal-title":"Hypertension"},{"issue":"12","key":"10.1016\/j.cca.2022.01.021_b0120","doi-asserted-by":"crossref","first-page":"e672","DOI":"10.1016\/S2468-2667(20)30191-2","article-title":"Cardiovascular risk factors in China: a nationwide population-based cohort study","volume":"5","author":"Li","year":"2020","journal-title":"Lancet Public Health"},{"issue":"6","key":"10.1016\/j.cca.2022.01.021_b0125","doi-asserted-by":"crossref","first-page":"780","DOI":"10.5993\/AJHB.44.6.4","article-title":"Differences in Overweight and Obesity between the North and South of China","volume":"44","author":"Tang","year":"2020","journal-title":"Am. J. Health Behav."}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898122000390?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898122000390?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T15:03:44Z","timestamp":1757862224000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898122000390"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":25,"alternative-id":["S0009898122000390"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2022.01.021","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The clinical value of PlGF and the sFlt1\/PlGF ratio in the management of hypertensive pregnancy disorders: A retrospective real-world study in China","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2022.01.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}